Overview

Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury

Status:
Unknown status
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to evaluate the evaluate the efficacy of Magnesium Isoglycyrrhizinate Injection in the prevention of antineoplastic chemotherapy related acute liver injury.
Phase:
Phase 4
Details
Lead Sponsor:
Cttq